Lushang Freda's EPS drop shows market judgment not just on e...
Lushang Freda's EPS drop shows market judgment not just on earnings. Current revenue growth implies management prioritizes it over EPS. Price moderation might mean the company's best stock days are past.
Investors More Bullish on Lushang Freda PharmaceuticalLtd (SHSE:600223) This Week as Stock Advances 3.9%, Despite Earnings Trending Downwards Over Past Five Years
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment